LAMISIL 250 (Lamisil 250 mg)
Generic Name: terbinafine
Pill imprint LAMISIL 250 has been identified as Lamisil 250 mg.
Lamisil is used in the treatment of onychomycosis, toenail; tinea corporis; cutaneous candidiasis; tinea capitis; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- terbinafine
- Imprint:
- LAMISIL 250
- Strength:
- 250 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0179
- Inactive Ingredients:
- silicon dioxide
hypromelloses
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55289-0513 | PDRX Pharmaceuticals Inc (repackager) |
| 54868-4008 | Physicians Total Care Inc (repackager) |
| 49999-0466 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More about Lamisil (terbinafine)
Consumer resources
- Other brands: Terbinex
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
